相关实验视频
Updated: May 8, 2025

07:37
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
2.5K
线粒体转录延长因子TEFM促进质瘤的恶性进展
Yin Wang1, Wenxuan Hu2, Boya Zhou3
1Institute for Excellence in Clinical Medicine of Kunshan First People's Hospital, Soochow University, Suzhou, China.
Cancer cell international
|December 24, 2024
概括
线粒体转录延长因子 (TEFM) 在侵袭性质瘤中被上调. 抑制TEFM会减缓瘤的生长和入侵,这表明TEFM是脑瘤的潜在治疗标.
科学领域:
- 神经瘤学神经瘤学
- 线粒体生物学 线粒体生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 质瘤,特别是质母细胞瘤 (GBM),是具有有限治疗选择的侵袭性脑瘤.
- 线粒体在癌症发育中起着至关重要的作用,但它们在质瘤进展中的具体参与尚未完全理解.
研究的目的:
- 为了研究线粒体转录延长因子 (TEFM) 在质瘤中的表达和功能.
- 确定TEFM在质瘤生长,侵袭和潜在的治疗点中的作用.
主要方法:
- 对质瘤中TEFM表达的癌症基因组图谱 (TCGA) 数据的分析.
- 在体外研究涉及TEFM沉默/敲击和质瘤细胞过度表达.
- 在裸体小鼠体内异种移植模型.
- 评估线粒体功能和表皮层-介质细胞过渡 (EMT) 标志物.
主要成果:
- 在质瘤组织中,TEFM转录水平显著升高,并与患者的存活率差相关.
- TEFM沉默/淘汰会抑制质瘤细胞的增殖,迁移,入侵,并诱导细胞亡.
- 过度表达TEFM增强了质瘤细胞的瘤性和EMT标志物的表达.
- TEFM 枯竭会损害线粒体呼吸,并在体内抑制瘤生长.
结论:
- TEFM是质瘤进展和侵袭的关键驱动因素.
- 在促进EMT和线粒体功能障碍方面,TEFM的作用突显了其在GBM中的重要性.
- 在质瘤治疗中,TEFM是一个有前途的新型治疗点.
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Master Transcription Regulators
6.7K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.7K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Electron Transport Chain: Complex I and II
9.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.5K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K

